nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are GAF scores reliable in routine clinical use?
|
Vatnaland, T. |
|
2007 |
115 |
4 |
p. 326-330 |
artikel |
2 |
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care
|
Amaddeo, F. |
|
2007 |
115 |
4 |
p. 320-325 |
artikel |
3 |
Biography
|
Munk-Jørgensen, Povl |
|
2007 |
115 |
4 |
p. 336 |
artikel |
4 |
Closing the 10/90 divide in global mental health research
|
Patel, Vikram |
|
2007 |
115 |
4 |
p. 257-259 |
artikel |
5 |
Comparative study of neurological soft signs in schizophrenia with onset in childhood, adolescence and adulthood
|
Biswas, P. |
|
2007 |
115 |
4 |
p. 295-303 |
artikel |
6 |
Letter to the editor
|
Święcicki, Łukasz |
|
2007 |
115 |
4 |
p. 335 |
artikel |
7 |
Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK
|
Pendlebury, J. |
|
2007 |
115 |
4 |
p. 286-294 |
artikel |
8 |
Patterns of social distance towards people suffering from schizophrenia in Austria: a comparison between the general public, relatives and mental health staff
|
Grausgruber, A. |
|
2007 |
115 |
4 |
p. 310-319 |
artikel |
9 |
Patterns, predictors and impact of substance use in early psychosis: a longitudinal study
|
Addington, J. |
|
2007 |
115 |
4 |
p. 304-309 |
artikel |
10 |
Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders
|
Eberhard, J. |
|
2007 |
115 |
4 |
p. 268-276 |
artikel |
11 |
Reply
|
Alaräisänen, Antti |
|
2007 |
115 |
4 |
p. 335 |
artikel |
12 |
The case for long-acting antipsychotic agents in the post-CATIE era
|
Nasrallah, H. A. |
|
2007 |
115 |
4 |
p. 260-267 |
artikel |
13 |
The destinies of the low- and middle-income country submissions
|
Konradsen, J. |
|
2007 |
115 |
4 |
p. 331-334 |
artikel |
14 |
Weight development in patients treated with risperidone: a 5-year naturalistic study
|
Neovius, M. |
|
2007 |
115 |
4 |
p. 277-285 |
artikel |